Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

Enhanced diabetes care to patients of south Asian ethnic origin (the United Kingdom Asian Diabetes Study) : a cluster randomised controlled trial

Tools
- Tools
+ Tools

Bellary, Srikanth, O'Hare, J. Paul, Raymond, Neil T., Gumber, Anil, Mughal, S., Szczepura, Ala, Kumar, Sudhesh and Barnett, A. H. (2008) Enhanced diabetes care to patients of south Asian ethnic origin (the United Kingdom Asian Diabetes Study) : a cluster randomised controlled trial. Lancet, Vol.371 (No.9626). pp. 1769-1776. doi:10.1016/S0140-6736(08)60764-3 ISSN 0140-6736.

Research output not available from this repository.

Request-a-Copy directly from author or use local Library Get it For Me service.

Official URL: http://dx.doi.org/10.1016/S0140-6736(08)60764-3

Request Changes to record.

Abstract

Background: Delivery of high-quality, evidence-based health care to deprived sectors of the community is a major goal
for society. We investigated the effectiveness of a culturally sensitive, enhanced care package in UK general practices for improvement of cardiovascular risk factors in patients of south Asian origin with type 2 diabetes.
Methods: In this cluster randomised controlled trial, 21 inner-city practices in the UK were assigned by simple
randomisation to intervention (enhanced care including additional time with practice nurse and support from a link
worker and diabetes-specialist nurse [nine practices; n=868]) or control (standard care [12 practices; n=618]) groups. All adult patients of south Asian origin with type 2 diabetes were eligible. Prescribing algorithms with clearly defined targets were provided for all practices. Primary outcomes were changes in blood pressure, total cholesterol, and glycaemic control (haemoglobin A1c) after 2 years. Analysis was by intention to treat. This trial is registered, number ISRCTN 38297969.
Findings: We recorded significant differences between treatment groups in diastolic blood pressure (1·91 [95% CI
–2·88 to –0·94] mm Hg, p=0·0001) and mean arterial pressure (1·36 [–2·49 to –0·23] mm Hg, p=0·0180), after adjustment for confounders and clustering. We noted no significant differences between groups for total cholesterol
(0·03 [–0·04 to 0·11] mmol/L), systolic blood pressure (–0·33 [–2·41 to 1·75] mm Hg), or HbA1c (–0·15%
[–0·33 to 0·03]). Economic analysis suggests that the nurse-led intervention was not cost effective (incremental
cost-eff ectiveness ratio £28 933 per QALY gained). Across the whole study population over the 2 years of the trial,
systolic blood pressure, diastolic blood pressure, and cholesterol decreased significantly by 4·9 (95% CI 4·0–5·9)
mm Hg, 3·8 (3·2–4·4) mm Hg, and 0·45 (0·40–0·51) mmol/L, respectively, and we recorded a small and non-significant increase for haemoglobin A1c (0·04% [–0·04 to 0·13]), p=0·290).
Interpretation: We recorded additional, although small, benefits from our culturally tailored care package that were
greater than the secular changes achieved in the UK in recent years. Stricter targets in general practice and further measures to motivate patients are needed to achieve best possible health-care outcomes in south Asian patients with diabetes.

Item Type: Journal Article
Subjects: R Medicine > RA Public aspects of medicine
R Medicine > RM Therapeutics. Pharmacology
Divisions: Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Health Sciences
Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Biomedical Sciences > Translational & Experimental Medicine > Metabolic and Vascular Health (- until July 2016)
Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School
Library of Congress Subject Headings (LCSH): Diabetes -- Treatment, South Asians -- Health and hygiene -- Great Britain, Diabetics -- Great Britain, Clinical trials
Journal or Publication Title: Lancet
Publisher: The Lancet Publishing Group
ISSN: 0140-6736
Official Date: 22 May 2008
Dates:
DateEvent
22 May 2008Published
Volume: Vol.371
Number: No.9626
Page Range: pp. 1769-1776
DOI: 10.1016/S0140-6736(08)60764-3
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Restricted or Subscription Access
Funder: Pfizer Inc., sanofi aventis (Firm), Servier Laboratories Ltd., Merck Sharp & Dohme/Schering-Plough, Takeda UK, Roche, Merck Pharmaceuticals, Daiichi-Sankyo UK, Boehringer Ingelheim Pharmaceuticals (BIP), Eli Lilly and Company, Novo Nordisk, Bristol-Meyers Squibb (BMS), Solvay Pharmaceuticals, Assurance Medical Society UK (AMS UK)

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item
twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us